Showing newest posts from
Posted March 24, 2017 at 6:00 AM EST
The company is a shining star in the business process outsourcing industry, says Vitaliy Katsenelson, CIO at Investment Management Associates.
Posted March 8, 2017 at 9:09 PM EST
Mylan NV's logo is displayed on a box of EpiPen 2-Pak allergy (Photo credit: Daniel Acker/Bloomberg).
In my previous column I explained why we are partial to pharmaceuticals, a sector politicians love to hate. Here’s how we’re playing our view.
Posted March 2, 2017 at 7:38 PM EST
Illustration by Alex Agius for Institutional Investor.
Pharmaceuticals stocks have been in the crosshairs of politicians on both sides of the aisle. But the noise has created buying opportunities.